Tactile Systems Technology Inc. (TCMD) is an innovative medical technology company that is committed to providing superior quality home healthcare devices for people suffering from chronic diseases at home. The company designs, manufactures, and provides unique therapeutic devices which are primarily used for treating lymphedema, venous ulcers, and other chronic conditions.
The company was established in 1995 and has its headquarters in Minneapolis, Minnesota. To increase the quality of life for patients with chronic health issues, Tactile Systems Technology, Inc. leverages cutting-edge technology to develop and deliver groundbreaking medical equipment that helps patients manage their health conditions at home.
Tactile Systems Technology markets two main products: the Flexitouch system and the Entre System. The Flexitouch system is an advanced intermittent pneumatic compression device used for both lymphedema and nonhealing venous leg ulcers treatment. The Flexitouch system has proved highly beneficial in reducing swelling, improving mobility, and lessening recurrent infections related to lymphedema. On the other hand, the Entre System is a basic, easy-to-use pneumatic compression device for patients who are unsuitable for or have no access to the Flexitouch system.
The company operates with a niche focus on the lymphedema market and constantly keeps an eye out for new opportunities in the post-acute care landscape. Its patient-centered model and commitment to research and development have facilitated its continued growth and a strong market position.
Tactile Systems Technology also aims to raise awareness about lymphedema among medical professionals and patients. The company collaborates often with healthcare professionals and researchers to further its understanding of lymphedema and develop solutions that can provide optimum care and assistance to those affected by this condition.
The organization places a strong emphasis on values such as collaboration, integrity, innovation, and patient-orientation. They believe in providing comprehensive services that engage patients in their care and treatment process, improve their health outcomes, and optimize their quality of life. Tactile Systems Technology is a publicly-traded company and is listed on NASDAQ under the symbol TCMD.
In summary, Tactile Systems Technology, Inc. is a company that strives to make a meaningful difference in the lives of people living with chronic diseases. Through their commitment to innovation and a focused approach to comprehensive care, they enhance the overall quality and accessibility of treatment for lymphedema and other chronic conditions.